54767414AMY3001 (FL)

54767414AMY3001 (FL)

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis


Study treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link